Katzenmeier C
Institut für Medizinrecht, Universität zu Köln, Albertus-Magnus-Platz, 50923, Köln, Deutschland.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Sep;55(9):1093-9. doi: 10.1007/s00103-012-1529-9.
Patient autonomy is a valuable asset. Under German law, the patient's right to self-determination is ensured by a corresponding duty of the physician to inform. Owing to various case laws of the courts over the last few decades, that duty, in all of its aspects (i.e., informing the patient about risks and benefits, about the diagnosis, about the course of treatment, about necessary patient compliance, and about potential treatment costs) has gained enormous jurisdictional and scientific attention as well as forensic importance. Established court practice has become highly elaborated and differentiated. Some precedents have, nevertheless, exceeded reasonable requirements for physicians, and moderation is advisable. The current plans concerning a Statute on the Protection of Patients' Rights in Germany aim at laying down the specific requirements for patients' informed consent, including what information has to be communicated and in what way. Such a goal is difficult, especially in light of regulatory techniques. The discussion about the statute seldom addresses the fact that the suitability of legal norms as a means for public guidance can be limited; in particular, they do not guarantee that a dialogue between patient and physician about risks and benefits will ensue on the basis of a partnership. Over-regulation can damage faith and confidence in the relationship between patients and physicians.
患者自主权是一项宝贵的资产。根据德国法律,医生相应的告知义务确保了患者的自决权。由于过去几十年法院的各种判例法,该义务的各个方面(即告知患者风险与益处、诊断情况、治疗过程、患者必要的配合以及潜在的治疗费用)受到了极大的司法和科学关注以及法医学重视。既定的法院实践已变得高度精细和有区别。然而,一些先例对医生的要求超出了合理范围,适度为宜。德国目前关于《患者权利保护法》的计划旨在规定患者知情同意的具体要求,包括必须传达哪些信息以及以何种方式传达。鉴于监管技术,这样一个目标很难实现。关于该法律的讨论很少涉及到这样一个事实,即法律规范作为公共指导手段的适用性可能是有限的;特别是,它们不能保证患者和医生会在伙伴关系的基础上就风险与益处展开对话。过度监管可能会损害患者与医生之间关系中的信任。